학술논문

Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study
Document Type
article
Source
Human Molecular Genetics. 28(16)
Subject
Biological Sciences
Genetics
Clinical Research
Human Genome
Prevention
Mental Health
Intellectual and Developmental Disabilities (IDD)
Brain Disorders
Pediatric
Autism
Aetiology
2.1 Biological and endogenous factors
Reproductive health and childbirth
Mental health
Autism Spectrum Disorder
Autistic Disorder
Biomarkers
Cadherins
Case-Control Studies
Child
Cytochrome P-450 CYP2E1
DNA Methylation
Disease Susceptibility
Epigenesis
Genetic
Female
Gene Expression Profiling
Genome-Wide Association Study
Humans
Insulin Receptor Substrate Proteins
Male
Maternal Exposure
Placenta
Pregnancy
Prenatal Exposure Delayed Effects
Risk
Signal Transduction
Wnt Proteins
Medical and Health Sciences
Genetics & Heredity
Language
Abstract
DNA methylation acts at the interface of genetic and environmental factors relevant for autism spectrum disorder (ASD). Placenta, normally discarded at birth, is a potentially rich source of DNA methylation patterns predictive of ASD in the child. Here, we performed whole methylome analyses of placentas from a prospective study MARBLES (Markers of Autism Risk in Babies-Learning Early Signs) of high-risk pregnancies. A total of 400 differentially methylated regions (DMRs) discriminated placentas stored from children later diagnosed with ASD compared to typically developing controls. These ASD DMRs were significantly enriched at promoters, mapped to 596 genes functionally enriched in neuronal development, and overlapped genetic ASD risk. ASD DMRs at CYP2E1 and IRS2 reached genome-wide significance, replicated by pyrosequencing and correlated with expression differences in brain. Methylation at CYP2E1 associated with both ASD diagnosis and genotype within the DMR. In contrast, methylation at IRS2 was unaffected by within DMR genotype but modified by preconceptional maternal prenatal vitamin use. This study therefore identified two potentially useful early epigenetic markers for ASD in placenta.